Circulating microRNA-21 as stable blood-based markers for patients with ISR after PCI

1Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

It recently has been reported that the in-stent restenosis (ISR) of expanded area after percutaneous coronary intervention (PCI) within six months can become a serious postoperative complication. A real-time quantitative PCR was used to analyze the expression of serum miR-21 in 33 ISR and 37 non-ISR patients after PCI. Expression of miR-21 was significantly higher in the ISR group compared with that in the NISR group, and a similar trend also occurred in factor- (TNF-a) level, Interleukin -6 (IL-6) level, and plaque area (PLA). However, a contrary trend occurred in the external elastic membrane area (EEM) and minimal lumen area (MLA). This study suggests that the increased expression of serum miR-21 is related to ISR after PCI, and miR-21 can be a new predictor of ISR.

Cite

CITATION STYLE

APA

Zhang, X., Xiao, X. P., Ren, X. A., & Xue, W. (2020). Circulating microRNA-21 as stable blood-based markers for patients with ISR after PCI. Heart Surgery Forum, 23(6), E756–E762. https://doi.org/10.1532/hsf.3245

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free